Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02791568 · ClinicalTrials.gov registry record
Advanced MRI for Uteroplacental Flow, Perfusion, Oxygenation & Inflammation
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 121
- Enrollment target
NCT02791568 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 121 participants.
The verdict
NCT02791568 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 121 participants
- Enrollment target
Study Summary
The purpose of the study is to develop advanced ultrasound (U/S) and Magnetic Resonance Imaging, known as MRI to study uteroplacental health. The goal of this study is to evaluate the blood and oxygen flow to the placenta using advanced U/S and MRI testing.
Interventions
- DRUG Ferumoxytol
- PROCEDURE MRI Scan
- PROCEDURE Ultrasound Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2017-01-31 |
| Est. Completion | 2020-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02791568
The ClinicalTrials.gov registry entry for NCT02791568 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ferumoxytol is the first listed.
NCT02791568 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02791568 about?
NCT02791568 is a clinical study titled "Advanced MRI for Uteroplacental Flow, Perfusion, Oxygenation & Inflammation". The purpose of the study is to develop advanced ultrasound (U/S) and Magnetic Resonance Imaging, known as MRI to study uteroplacental health. The goal of this study is to evaluate the blood and oxygen flow to the placenta using advanced U/S and MRI testing.
What is the current status of trial NCT02791568?
This trial is currently completed. The enrollment target is 121 participants. The study started on 2017-01-31. Estimated completion is 2020-07-31.
What interventions are being tested in trial NCT02791568?
The interventions under investigation include: Ferumoxytol (DRUG), MRI Scan (PROCEDURE), Ultrasound Scan (PROCEDURE).
Who is sponsoring clinical trial NCT02791568?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.